Safety and Efficacy of Triple Therapy With Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Human Immunodeficiency Virus Type 2 Patients: Results From a 48-Week Phase 2 Study

AuthID
 P-00Y-PBS
21
Author(s)
Pacheco, P
·
Marques, N
·
Rodrigues, P
·
Mansinho, K
·
Maltez, F
·
Janeiro, N
·
Franco, C
·
Trigo, D
·
Batista, J
·
Duque, L
·
[+1]·
Aleixo, MJ
·
Silva, AR
·
Tavares, R
·
Alves, J
·
Peres, S
·
Povoas, D
·
Lino, S
·
Araujo, V
·
Lopes, C
View all authors
Document Type
Article in Press
Year published
2023
Published
in CLINICAL INFECTIOUS DISEASES, ISSN: 1058-4838
Volume: 77, Issue: 5, Pages: 740-748 (10)
Indexing
Wos®
Scopus®
Crossref®3
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 37288954
SCOPUS: 2-s2.0-85170717511
Wos: WOS:001018618800001
Source Identifiers
ISSN: 1058-4838
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Pacheco, P;   2 Marques, N;   3 Rodrigues, P;
4 Mansinho, K;   5 Maltez, F;   6 Janeiro, N;
7 Franco, C;   8 Trigo, D;   9 Batista, J;
10 Duque, L;   11 Lopes, MJ;   12 Aleixo, MJ;
13 Silva, AR;   14 Tavares, R;   15 Alves, J;
16 Peres, S;   17 Povoas, D;   18 Lino, S;
19 Gomes, P;   20 Araujo, V;   21 Lopes, C;

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service